A Study of Dasatinib Plus Reduced Intensive Consolidation Chemotherapy in Ph+ Adult ALL

NCT05026229 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Philadelphia-Positive Acute Lymphoblastic Leukemia
ALL, Adult

Interventions

DRUG: dasatinib plus consolidation chemotherapy with vincristine and prednisone
DRUG: dasatinib plus consolidation chemotherapy with high-dose methotrexate and cytarabine

Sponsor

First Affiliated Hospital Xi'an Jiaotong University